well and i think that s what most of us expect. obviously, we will have to see how it plays out. mike: dr. ashish jha, the antiviral drug developed by merck was approved thursday by federal regulators and found to cut the risk of hospitalization and death in high risk patients by 30%, but some experts fear it will fuel the rise of new variants or could cause mutations and people who take it is that a legitimate concern? you know it is a legitimate concern, mike that s why i m not show so sure we want to use that. the pfizer pill is, i think, a much much better option and that will probably become the standard of care once it s more widely available. mike: earlier this week president biden had this to say about children in the school. covid-19 is a scary, but the science is clear , children are safe as safe in school as they are anyplace assuming the appropriate cautions have been taken
what most of us expect. obviously, we will have to see how it plays out. mike: dr. ashish jha, the antiviral drug developed by merck was approved thursday by federal regulators and found to cut the risk of hospitalization and death in high risk patients by 30%, but some experts fear it will fuel the rise of new variants or could cause mutations and people who take it is that a legitimate concern? you know it is a legitimate concern, mike that s why i m not show so sure we want to use that. the pfizer pill is, i think, a much much better option and that will probably become the standard of care once it s more widely available. mike: earlier this week president biden had this to say about children in the school. covid-19 is a scary, but the science is clear , children are safe as safe in school as they are anyplace assuming the appropriate cautions have been taken